Immunopathogenesis in hepatitis C virus cirrhosis

Clinical Science

Volumn 112, Issue 3-4, 2007, Pages 141-155

  Spengler, Ulrich ^a   Nattermann, Jacob ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Antibody; Cirrhosis; Hepatitis C virus (HCV); Immune response; Liver damage; T cell

Indexed keywords

CD81 ANTIGEN; GLYCOPROTEIN E2; PERFORIN; TOLL LIKE RECEPTOR; VIRUS ANTIBODY;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOTOXICITY; DISEASE COURSE; FIBROGENESIS; FIBROSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; LIVER CIRRHOSIS; LIVER INJURY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANTIBODIES, VIRAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, CELLULAR; LIVER CIRRHOSIS; T-LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTORS;

EID: 33846985915     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20060171     Document Type: Review

References (217)

1. Krahn, M., Wong, J. B., Heathcote, J., Scully, L. and Seeff, L. (2004) Estimating the prognosis of hepatitis C patients infected by transfusion in Canada between 1986 and 1990. Med. Decis. Making 24, 20-29
2. Gale, M. and Foy, E. M. (2005) Evasion of intracellular host defence by hepatitis C virus. Nature 436, 939-945
3. Bowen, D. G. and Walker, C. M. (2005) Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436, 946-952
4. Brillanti, S., Foli, M., Gaiani, S., Masci, C., Miglioli, M. and Barbara, L. (1993) Persistent hepatitis C viraemia without liver disease. Lancet 341, 464-465
5. Alberti, A., Morsica, G., Chemello, L. et al. (1992) Hepatitis C viremia and liver disease in symptom-free individuals with anti-HCV. Lancet 340, 697-698
6. Farci, P., Alter, H. J., Shimoda, A. et al. (1996) Hepatitis C virus-associated fulminant hepatic failure. N. Engl. J. Med. 335, 631-634
7. Collier, J. and Heathcote, J. (1998) Hepatitis C viral infection in the immunosuppressed patient. Hepatology 27, 2-6
8. Gruber, A., Lundberg, L. G. and Bjorkholm, M. (1993) Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy. J. Intern. Med. 234, 223-225
9. Fan, F. S., Tzeng, C. H., Hsiao, K. I., Hu, S. T., Liu, W. T. and Chen, P. M. (1991) Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant. 8, 417-420
10. Gholson, C. F., Morgan, K., Catinis, G. et al. (1997) Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. Am. J. Gastroenterol. 92, 1788-1792
11. Bantel, H. and Schulze-Osthoff, K. (2003) Apoptosis in hepatitis C infection. Cell Death Differ. 10, 548-558
12. Poynard, T., Bedossa, P. and Opolon, P. (1997) Natural history of fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINVIR and DOSVIRC groups. Lancet 349, 825-832
13. Iwasaki, A. and Medzhitov, R. (2004) Toll like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995
14. Schwabe, R. E, Seki, E. and Brenner, D. A. (2006) Toll-like receptor signalling in the liver. Gastroenterology 130, 1886-1900
15. Hertzog, P. J., O'Neill, L. A. and Hamilton, J. A. (2003) The interferon in TLR signaling: more than just antiviral. Trends Immunol. 24, 534-539
16. Sharma, S., ten Oever, B.R., Grandvaux, N., Zhou, G. P., Lin, R. and Hiscott, J. (2003) Triggering the interferon antiviral response through a novel IKK-related pathway. Science 300, 1148-1151
17. Fitzgerald, K. A., McWhirter, S. M., Faia, K. L. et al. (2003) IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496
18. Yamamoto, M., Sato, S., Hemmi, H. et al. (2003) Role of the adaptor TRIP in the MyD88 independent Toll-like receptor pathway. Science 301, 640-643
19. Feld, J. J and Hoofnagle, J. H. (2005) Mechanism and action of interferon and ribavirin in treatment of hepatitis C. Nature 436, 967-972
20. Tai, D.-I., Tsai, S.-L., Chen, Y.-M. et al. (2000) Activation of nuclear factor κB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 31, 656-664
21. Yoneyama, M., Kikuchi, M., Natsukawa, T. et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737
22. Kawai, T., Takahasi, K., Sato, S. et al. (2005) IPS-1 an adaptor triggering RIG-I- and Mda5-mediated type 1 interferon induction. Nat. Immunol. 6, 981-988
23. Seth, R. B., Sun, L., Ea, C. K. and Chen, Z. J. (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 122, 669-682
24. Xu, L. G., Wang, Y. Y., Han, K. J., Li, L. Y., Zhai, Z. and Shu, H. B. (2005) VISA is an adaptor protein required for virus-triggered IFN-β signaling. Mol. Cell 19, 727-740
25. Meylan, E., Curran, J., Hofmann, K. et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-1172
26. Li, K., Foy, E., Ferreon, J. C. et al. (2005) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Nad. Acad. Sci. U.S.A. 102, 2992-2997
27. Gale, M. and Foy, E. M. (2005) Evasion of intracellular host defence by hepatitis C virus. Nature 436, 939-945
28. Polyak, S. J., Khabar, K. S., Paschal, D. M. et al. (2001) Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 75, 6095-6106
29. Khabar, K. S., Al-Zoghaibi, F., Al-Ahdal, M. N. et al. (1997) The α chemokine, interleukin 8, inhibits the antiviral actions of interferon α. J. Exp. Med. 186, 1077-1085
30. Polyak, S. J., Khabar, K. S., Rezeig, M. and Gretch, D. R. (2001) Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J. Virol. 75, 6209-6211
31. Dolganiuc, A., Garcia, C., Kodys, K. and Szabo, G. (2006) Distinct toll-like receptor expression in monocytes and T-cells in hepatitis C. World J. Gastroenterol. 28, 1198-1204
32. Mozer-Lzewska, I., Sluzewski, W., Kaczmarek, M. et al. (2005) Tissue localization of Toll-like receptors in biopsy specimens of liver from children infected with hepatitis C virus. Scand. J. Immunol. 62, 407-412
33. Machida, K., Cheng, K. T., Sung, V. M., Levine, A. M., Foung, S. and Lai, M. M. (2006) Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J. Virol. 80, 866-874
34. Dolganiuc, A., Oak, S., Kodys, K. et al. (2004) Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127, 1513-1524
35. Pileri, P., Uematsu, Y., Campagnoli, S. et al. (1998) Binding of hepatitis C virus to CD81. Science 282, 938-941
36. Cocquerel, L., Kuo, C. C., Dubuisson, J. and Levy, S. (2003) CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J. Virol. 77, 10677-10683
37. Levy, S., Todd, S. C. and Maecker, H. T. (1998) CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16, 89-109
38. Levy, S. and Shoham, T. (2005) The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 5, 136-148
39. Rosa, D., Saletti, G., De Gregorio, E. et al. (2005) Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc. Natl. Acad. Sci. U.S.A. 102, 18544-18549
40. Tseng, C. T., Tseng, C. T. and Klimpel, G. R. (2002) Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195, 43-50
41. Crotta, S., Stilla, A., Wack, A. et al. (2002) Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195, 35-41
42. Tseng, C. T., Miskovsky, E., Houghton, M. and Klimpel, G. R. (2001) Characterization of liver T-cell receptor γδ T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections. Hepatology 33, 1312-1320
43. Nuti, S., Rosa, D., Valiante, N. M. et al. (1998) Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment fornVα24+ T cells and rapid elimination of effector cells by apoptosis. Eur. J. Immunol. 28, 3448-3455
44. Agrati, C., D'Offizi, G., Narciso, P. et al. (2001) Lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons. Mol. Med. 7, 11-19
45. Agrati, C., D'Offizi, G., Narciso, P. et al. (2001) Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 17, 1357-1363
46. Witherden, D. A., Boismenu, R. and Havran, W. L. (2000) CD81 and CD28 costimulate T cells through distinct pathways. J. Immunol. 165, 1902-1909
47. Lichterfeld, M., Leifeld, L., Nischalke, H. D. et al. (2002) Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. J. Infect. Dis. 185, 1803-1807
48. Nattermann, J., Nischalke, H. D., Feldmann, G., Ahlenstiel, G., Sauerbruch, T. and Spengler, U. (2004) Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5. J. Viral Hepatol. 11, 519-526
49. Nattermann, J., Zimmermann, H., Iwan, A. et al. (2006) Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. Hepatology 44, 945-954
50. Kanto, T., Hayashi, N., Takehara, T. et al. (1999) Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 162, 5584-5591
51. Auffermann-Gretzinger, S., Keeffe, E. B. and Levy, S. (2001) Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97, 3171-3176
52. Bain, C., Fatmi, A., Zoulim, F., Zarski, J. P., Trepo, C. and Inchauspe, G. (2001) Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120, 512-524
53. Kanto, T., Inoue, M., Miyatake, H. et al. (2004) Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 190, 1919-1926
54. Ulsenheimer, A., Gerlach, J. T., Jung, M. C. et al. (2005) Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology 41, 643-651
55. Volkov, Y., Long, A., Freeley, M. et al. (2006) The hepatitis C envelope 2 protein inhibits LFA-1-transduced protein kinase C signaling for lymphocyte migration. Gastroenterology 130, 482-492
56. Mazzocca, A., Sciametta, S. C., Carloni, V. et al. (2005) Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. J. Biol. Chem. 280, 11329-11339
57. Bataller, R., Paik, Y. H., Lindquist, J. N., Lemasters, J. J. and Brenner, D. A. (2004) Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology 126, 529-540
58. Choi, S. H. and Hwang, S. B. (2006) Modulation of the transforming growth factor-β signal transduction pathway by nepatitis C virus nonstructural 5A protein. J. Biol. Chem. 281, 7468-7478
59. Uemura, T., Wang, R. Y.-H., Schechterly, C., Shih, J. W.-K., Kiyosawa, K. and Alter, H. J. (2006) Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C. Hepatology 43, 91-99
60. Nattermann, J., Schneiders, A. M., Leifeld, L. et al. (2005) Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC). J. Hepatol. 42, 499-504
61. Pohlmann, S., Zhang, J., Baribaud, F. et al. (2003) Hepatitis C glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 77, 4070-4080
62. Dumonceaux, J., Cormier, E. G., Kajumo, F. et al. (2003) Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1. J. Virol. 77, 13418-13424
63. Lozach, P. Y., Lortat-Jacob, H., de Lacroix de Lavalette, A. et al. (2003) DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J. Biol. Chem. 278, 20358-20366
64. Lozach, P. Y., Amara, A., Bartosch, B. et al. (2004) C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J. Biol. Chem. 279, 32035-32045
65. Nattermann, J., Ahlenstiel, G., Berg, T. et al. (2006) The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection. J. Viral Hepatol. 13, 42-46
66. Khakoo, S. I., Thio, C. L., Martin, M. P. et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872-874
67. Corano, J., Toro, F., Rivera, H. et al. (1997) Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin. Exp. Immunol. 109, 451-457
68. Düesberg, U., Schneiders, A. M., Flieger, D., Inchauspé, G., Sauerbruch, T. and Spengler, U. (2001) Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C. J. Hepatol. 35, 650-657
69. Morishima, C., Paschal, D. M., Wang, C. C. et al. (2006) Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 43, 573-580
70. Moretta, L. and Moretta, A. (2004) Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23, 255-259
71. Nattermann, J., Nischalke, H. D., Hofmeister, V. et al. (2005) The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am. J. Pathol. 166, 443-453
72. Jinushi, M., Takehara, T., Tatsumi, T. et al. (2004) Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J. Immunol. 173, 6072-6081
73. Nattermann, J., Feldmann, G., Ahlenstiel, G., Langhans, B., Sauerbruch, T. and Spengler, U. (2006) Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55, 869-877
74. Pinzani, M. and Marra, F. (2001) Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver Dis. 21, 397-416
75. Radaeva, S., Sun, R., Jarugga, B., Nguyen, V. T., Tian, Z. and Gao, B. (2006) Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130, 435-452
76. Melhem, A., Muhanna, N., Bishara, A. et al. (2006) Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J. Hepatol. 45, 60-71
77. Farci, P., Alter, H. J., Govindarajan, S. et al. (1992) Lack of protective immunity against reinfection with hepatitis C virus. Science 258, 135-140
78. Lai, M. E., Mazzoleni, A. P., Argiolu, F. et al. (1994) Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343, 388-390
79. Cooper, S., Erickson, A. L., Adams, E. J. et al. (1999) Analysis of a successful immune response against hepatitis C virus. Immunity 10, 439-449
80. Post, J. J., Pan, Y., Freeman, A. J. et al. (2004) Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prison study (HITS) cohort. J. Infect. Dis. 189, 1846-1855
81. Farci, P., Shimoda, A., Coiana, A. et al. (2000) The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-344
82. Farci, P., Alter, H. J., Wong, D. C. et al. (1994) Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. U.S.A. 91, 7792-7796
83. Farci, P., Shimoda, A., Wong, D. et al. (1996) Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl. Acad. Sci. U.S.A. 93, 15394-15399
84. Bartosch, B., Bukh, J., Meunier, J. C. et al. (2003) In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralizing epitopes. Proc. Natl. Acad. Sci. U.S.A. 100, 14199-14204
85. Logvinoff, C., Major, M. E., Oldach, D. et al. (2004) Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc. Natl. Acad. Sci. U.S.A. 101, 10149-10154
86. Meunier, J. C., Engle, R. E., Faulk, K. et al. (2005) Evidence for cross-genotype neutralization of hepatitis C virus pseudoparticles and enhancement of infectivity by apoplipoprotein C1. Proc. Natl. Acad. Sci. U.S.A. 102, 4560-4565
87. Yu, M. Y., Bartosch, B., Zhang, P. et al. (2004) Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. Proc. Natl. Acad. Sci. U.S.A. 101, 7705-7710
88. Farci, P., Quinti, I., Farci, S. et al. (2006) Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc. Natl. Acad. Sci. U.S.A. 103, 8475-8480
89. Bowen, D. G. and Walker, C. M. (2005) Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436, 946-952
90. Koziel, M. J., Dudley, D., Wong, J. T., Dienstag, J., Houghton, M., Ralston, R. and Walker, B. D. (1992) Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149, 3339-3344
91. Koziel, M. J., Dudley, D., Afdahl, N. et al. (1993) Hepatitis C virus (HCV)- specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67, 7522-7532
92. Cerny, A., McHutchinson, G., Pasquinelli, C. et al. (1995) Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95, 521-530
93. Battegay, M., Fikes, J., Di Bisceglie, A. M. et al. (1995) Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA A2.1molecules. J. Virol. 69, 2462-2470
94. Kita, H., Hiroishi, K., Moriyama, T. et al. (1995) A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein. J. Gen. Virol. 76, 3189-3193
95. Wentworth, P. A., Sette, A., Celis, E. et al. (1996) Identification of A2 -restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int. Immunol. 8, 651-659
96. Kaneko, T., Nakamura, I., Kita, H., Hiroishi, K., Moriyama, T. and Imawari, M. (1996) Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein. J. Gen. Virol. 77, 1305-1309
97. Chang, K. M., Rehermann, B., McHutchinson, J. G. et al. (1997) Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J. Clin. Invest. 100, 2376-2385
98. Wong, D. K., Dudley, D. D., Afdahl, N. H. et al. (1998) Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J. Immunol. 160, 1479-1488
99. Lauer, G. M., Ouchi, K., Chung, R. T. et al. (2002) Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J. Virol. 76, 6104-6113
100. Lauer, G. M., Barnes, E., Lucas, M. et al. (2004) High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127, 924-936
101. Lauer, G. M., Lucas, M., Timm, J. et al. (2005) Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. J. Virol. 79, 12979-12988
102. Neumann-Haefelin, C., McKiernan, S., Ward, S. et al. (2006) Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 43, 563-572
103. Botarelli, P., Brunetto, M. R., Minutello, M. A. et al. (1993) T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104, 580-587
104. Ferrari, C., Valli, A., Galati, L. et al. (1994) T cell response to structural and nonstructural hepatitis C virus antigen in persistent and self-limited hepatitis C virus infections. Hepatology 19, 286-295
105. Hoffmann, R. M., Diepolder, H. M., Zachoval, R. et al. (1995) Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21, 632-638
106. Missale, G., Bretoni, R., La Monaca, V. et al. (1996) Different clinical behaviours of acute hepatitis C virus infection are associated with different vigor of the antiviral cell-mediated immune response. J. Clin. Invest. 98, 706-714
107. Diepolder, H. M., Gerlach, J. T., Zachoval, R. et al. (1997) Immunodominant CD4+ T-cell epitopes within nonstructural protein 3 in acute hepatitis C virus infection. J. Virol. 71, 6011-6019
108. Schirren, C. A., Jung, M. C., Gerlach, J. T. et al. (2000) Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 32, 597-603
109. Day, C. L., Lauer, G. M., Robbins, G. K. et al. (2002) Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J. Virol. 76, 12584-12595
110. Day, C. L., Seth, N. P., Lucas, M. et al. (2003) Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 112, 831-842
111. Schulze zur Wiesch, J., Lauer, G. M., Day, C. L. et al. (2005) Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J. Immunol. 175, 3603-3613
112. Gerlach, J. T., Ulsenheimer, A., Grüner, N. H. et al. (2005) Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J. Virol. 79, 12425-12433
113. Lechner, E, Wong, D. K., Dunbar, P. R. et al. (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191, 1499-1512
114. Thimme, R., Oldach, D., Chang, K. M., Steiger, C., Ray, S. C. and Chisari, F. V. (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194, 1395-1406
115. Diepolder, H. M., Zachoval, R., Hoffmann, R. M. et al. (1995) Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346, 1006-1007
116. Rehermann, B., Chang, K. M., McHutchinson, J. et al. (1996) Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. 70, 7092-7102
117. Hiroishi, K., Kita, H., Kojima, M. et al. (1997) Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 25, 705-712
118. Nelson, D. R., Marousis, C. G., Davis, G. L. et al. (1997) The role of hepatitis C virus specific cytotoxic T lymphocytes in chronic hepatitis C.J. Immunol. 158, 1473-1481
119. Koziel, M. J., Wong, D. K. H., Dudley, D., Houghton, M. and Walker, B. D. (1997) Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J. Infect. Dis. 176, 859-866
120. Takaki, A., Wiese, M., Maertens, G. et al. (2000) Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6, 578-582
121. Lechner, F., Grüner, N. H., Urbani, S. et al. (2000) CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30, 2479-2487
122. Cox, A. L., Mosbruger, T., Lauer, G. M., Pardoll, D., Thomas, D. L. and Ray, S. C. (2005) Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42, 104-112
123. Gerlach, J. T., Diepolder, H. M., Jung, M. C. et al. (1999) Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 117, 933-941
124. Folgori, A., Spada, E., Pezzanera, M. et al. (2006) Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut 55, 1012-1019
125. He, X. S., Rehermann, B., Lopez-Labrador, F. X. et al. (1999) Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc. Natl. Acad. Sci. U.S.A. 96, 5692-5697
126. Grabowska, A. M., Lechner, F., Klenerman, P. et al. (2001) Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur. J. Immunol. 31, 2388-2394
127. Grüner, N. H., Lechner, F., Jung, M. C. et al. (2001) Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 75, 5550-5558
128. Wedemeyer, H., He, X. S., Nascimbeni, M. et al. (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169, 3447-3458
129. Lechmann, M., Ihlenfeldt, H. G., Braunschweiger, I. et al. (1996) T and B cell responses to different hepatitis C virus antigens in patients with chronic hepatitis and healthy anti-HCV positive blood donors without viremia. Hepatology 24, 790-795
130. Woitas, R., Lechmann, M., Jung, G., Kaiser, R., Sauerbruch, T. and Spengler, U. (1997) CD30 induction and cytokine profiles in HCV core-specific peripheral blood T lymphocytes. J. Immunol. 159, 1012-1018
131. Lechmann, M., Woitas, R. P., Langhans, B. et al. (1999) Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J. Hepatol. 31, 971-978
132. Ulsenheimer, A., Gerlach, J. T., Grüner, N. H. et al. (2003) Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37, 1189-1198
133. Tsai, S.-L., Liaw, Y.-F., Chen, M.-H., Huang, C.-Y. and Kuo, G. C. (1997) Detection of type 2-like T-helper cells in hepatitis C virus infection: implication for hepatitis C chronicity. Hepatology 25, 449-458
134. Reiser, M., Marousis, C. G., Nelson, D. R. et al. (1997) Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J. Hepatol. 26, 471-78
135. Cacciarelli, T. V., Martinez, O. M., Gish, R. G., Villanueva, J. C. and Krams, S. M. (1996) Immunregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology 24, 6-9
136. Semmo, N., Day, C. L., Ward, S. M. et al. (2005) Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 41, 1019-1028
137. Langhans, B., Braunschweiger, I., Schweitzer, S. et al. (2001) Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro. Immunology 102, 460-465
138. Langhans, B., Braunschweiger, I., Nischalke, H. D., Nattermann, J., Sauerbruch, T. and Spengler, U. (2006) Presentation of the HCV-derived lipopeptide LP20-LP44 by dendritic cells enhances function of in vitro-generated CD4+ T cells via up-regulation of TLR2. Vaccine 24, 3066-3075
139. Cramp, M. E., Rossol, S., Chokshi, S., Carucci, P., Williams, R. and Naoumov, N. V. (2000) Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118, 346-355
140. Bowen, D. G. and Walker, C. M. (2005) Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J. Exp. Med. 201, 1709-1714
141. Meyer-Olson, D., Shoukry, N. H., Brady, K. W. et al. (2004) Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J. Exp. Med. 200, 307-319
142. Cox, A. L., Mosbruger, T., Map, Q. et al. (2005) Cellular immune selection with hepatitis C virus persistence in humans. J. Exp. Med. 201, 1741-1752
143. Timm, J., Lauer, G. M., Kavanagh, D. G. et al. (2004) CD8 epitope escape and reversion in acute HCV infection. J. Exp. Med. 200, 1593-1604
144. Ray, S. C., Fanning, L., Wang, X. H., Netski, D. M., Kenny-Walsh, E. and Thomas, D. L. (2005) Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J. Exp. Med. 201, 1753-1759
145. Seifert, U., Liermann, H., Racanelli, V. et al. (2004) Hepatitis C virus mutation affects proteasomal epitope processing. J. Clin. Invest. 114, 250-259
146. Erickson, A. L., Kimura, Y., Igarashi, S. et al. (2001) The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15, 883-895
147. Urbani, S., Amadei, B., Cariani, E. et al. (2005) The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection. J. Immunol. 175, 7519-7529
148. Grakoui, A., Shoukry, N. H., Woollard, D. J. et al. (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302, 659-662
149. Larsson, M., Babcock, E., Grakoui, A. et al. (2004) Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus. J. Virol. 78, 6151-6161
150. Moskophidis, D., Laine, E. and Zinkernagel, M. (1993) Peripheral clonal deletion of antiviral memory CD8+ T cells. Eur. J. Immunol. 23, 3306-3311
151. Wherry, E. J. and Ahmed, R. (2004) Memory CD8 T cell differentiation during viral infection. J. Virol. 78, 5535-5545
152. Grüner, N. H., Lechner, F., Jung, M. C. et al. (2001) Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 75, 5550-5558
153. Appay, V., Dunbar, P. R., Callan, M. et al. (2002) Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8, 379-385
154. Zajac, A. J., Blattman, J. N., Murali-Krishna, K. et al. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205-2213
155. Khanolkar, A., Fuller, M. J. and Zajac, A. J. (2004) CD4 T cell-dependent CD8 T cell maturation. J. Immunol. 172, 2834-2844
156. Lucas, M., Vargas-Cuero, A. L., Lauer, G. M. et al. (2004) Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells. J. Immunol. 172, 1744-1753
157. Barber, D. L., Wherry, E. J., Masoust, D. et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687
158. Chang, K.-M. (2005) Regulatory T cells and the liver: a new piece of the puzzle. Hepatology 41, 700-702
159. Koziel, M. J., Dudley, D., Afdhal, N. et al. (1995) HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 96, 2311-2321
160. + T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113, 963-972
161. Sugimoto, K., Ikeda, F., Stadanlick, J., Nunes, F. A., Alter, H. J. and Chang, K. M. (2003) Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38, 1437-1448
162. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40, 1062-1071
163. Böttler, T., Spangenberg, H. C., Neumann-Haefelin, C. et al. (2005) T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD7+ T cells during chronic hepatitis C virus infection. J. Virol. 79, 7860-7867
164. Rushbrook, S. M., Ward, S. M., Unitt, E. et al. (2005) Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J. Virol. 79, 7852-7859
165. Kurokohchi, K., Masaki, T., Arima, K. et al. (2003) CD28-negative CD8-positive cytotoxic T lymphocytes mediate hepatocellular damage in hepatitis C virus infection. J. Clin. Immunol. 23, 518-527
166. Freeman, A. J., Pan, Y., Harvey, C. E. et al. (2003) The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J. Hepatol. 38, 349-356
167. Bertoletti, A., D'Elios, M. M., Boni, C. et al. (1997) Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and C virus infections. Gastroenterology 112, 193-199
168. Ando, K., Hiroishi, K., Kaneko, T. et al. (1997) Perforin, Fas/Fas ligand and TNF pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 158, 5283-5291
169. Gremion, C., Grabscheid, B., Woelk, B. et al. (2004) Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction. J. Virol. 78, 2152-2157
170. Selin, L. K. and Welsh, R. M. (2004) Plasticity of T cell memory responses in viruses. Immunity 20, 5-16
171. Urbani, S., Amadei, B., Fisicaro, P. et al. (2005) Heterologous T cell immunity in severe hepatitis C virus infection. J. Exp. Med. 201, 675-680
172. Dumoulin, F. L., Bach, A., Leifeld, L. et al. (1997) Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C.J. Infect. Dis. 175, 681-685
173. Leroy, V., Vigan, I., Mosnier, J.-F. et al. (2003) Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 38, 829-841
174. Napoli, J., Bishop, G. A., McGuinness, P. H., Painter, D. M. and McCauchghan, G. W. (1996) Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 4, 759-765
175. McGuiness, P. H., Painter, D., Davies, S. and McCaughan, G. W. (2000) Increases in intrahepatic CD68 positive cells, MAC387 positive cells and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 46, 260-269
176. Toyonaga, T., Hino, O., Sugai, S. et al. (1994) Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc. Natl. Acad. Sci. U.S.A. 91, 614-618
177. Patzwahl, R., Meier, V., Ramadori, G. and Mihm, S. (2001) Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J. Virol. 75, 1332-1338
178. Shields, P. L., Morland, C. M., Salmon, M., Qin, S., Hübscher, S. G. and Adams, D. H. (1999) Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J. Immunol. 163, 6236-6243
179. Romagnani, P., Annunziato, F., Lazzeri, E. et al. (2001) Interferon-inducible protein 10, monokine induced by interferon gamma and interferon-inducible T-cell α chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) αβ+ CD8+ single-positive T cells, TCRγδ+ T cells and natural killer-type cells in human thymus. Blood 97, 601-607
180. Bonacchi, A., Petrai, I., Defranco, R. M. et al. (2003) The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 125, 1060-1076
181. Medema, J. P., Toes, R. E., Scaffidi, C. et al. (1997) Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis. Eur. J. Immunol. 27, 3492-3498
182. Sarin, A., Haddad, E. K. and Henkart, P. A. (1998) Caspase dependence of target cell damage induced by cytotoxic lymphocytes. J. Immunol. 161, 2810-2816
183. Feldmann, G., Haouzi, D., Moreau, A. et al. (2000) Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice. Hepatology 31, 674-683
184. Rodriguez, I., Matsuura, K., Ody, C., Nagata, S. and Vassalli, P. (1996) Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. 184, 2067-2072
185. Lacronique, V., Migon, A., Fabre, M. et al. (1996) Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 2, 80-86
186. Ray, R. B., Meyer, K. and Ray, R. (1996) Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226, 176-182
187. Ruggieri, A., Harada, T., Matsuura, Y. and Miyamura, T. (1997) Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229, 68-76
188. Ray, R. B., Meyer, K., Steele, R., Shrivastava, A., Aggarwal, B. B. and Ray, R. (1998) Inhibition of tumor necrosis factor (TNF-α) - mediated apoptosis by hepatitis C virus core protein. J. Biol. Chem. 273, 2256-2259
189. Matsumoto, M., Hsieh, N., Zhu, T. et al. (1997) Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-B receptor. J. Virol. 71, 1301-1307
190. Chen, C. M., You, L. R., Hwang, L. H. and Lee, Y. H. (1997) Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-β receptor modulates the signal pathway of the lymphotoxin-β receptor. J. Virol. 71, 9417-9422
191. Zhu, N., Khoshnan, A., Schneider, R. et al. (1998) Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virology. 72, 3691-3697
192. Marusawa, H., Hijikata, M., Chiba, T. and Shimotohno, K. (1999) Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation. J. Virol. 73, 4713-4720
193. Dumoulin, F. L., von dem Bussche, A., Soehne, J., Sauerbruch, T. and Spengler, U. (1999) Hepatitis C virus core protein does not inhibit apoptosis in human hepatoma cells. Eur. J. Clin. Invest. 29, 940-946
194. Honda, M., Kaneko, S., Shimazaki, T. et al. (2000) Hepatitis C core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology 31, 1351-1359
195. Hahn, C. S., Cho, Y. G., Khan, B. S., Lester, I. M. and Hahn, Y. S. (2000) The HCV core protein acts as positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 266, 127-137
196. Zhu, N., Ware, C. F. and Lai, M. M. (2001) Hepatitis C core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology 283, 178-187
197. Gonzalez-Amaro, R., Garcia-Monzon, C., Garcia-Buey, L. et al. (1994) Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179, 841-848
198. Spengler, U., Zachoval, R., Gallati, H. et al. (1996) Serum levels and in situ expression of TNF-α and TNF-α binding proteins in inflammatory liver diseases. Cytokine 8, 864-872
199. Tokushige, K., Yamaguchi, N., Ikeda, I., Hashimoto, E., Yamauchi, K. and Hayashi, N. (2000) Significance of soluble TNF receptor-I in acute-type fulminant hepatitis. Am. J. Gastroenterol. 95, 2040-2046
200. Mita, E., Hayashi, N., Iio, S. et al. (1994) Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem. Biophys. Res. Commun. 204, 468-474
201. Hiramatsu, N., Hayashi, N., Katayama, K. et al. (1994) Immunohistological detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19, 1354-1359
202. Hayashi, J., Kishihara, Y., Yamaji, K. et al. (1995) Hepatitis C viral quaisspecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 25, 697-701
203. Okazaki, M., Hino, K., Fuji, K., Kobayashi, N. and Okita, K. (1996) Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 41, 2453-2458
204. Ferenbach, D. A., Haydon, G. H., Rae, F., Malcomson, R. D. and Harrison, D. J. (1997) Alteration in mRNA levels of Fas splice variants in hepatitis C-infected liver. J. Pathol. 183, 299-304
205. Pianko, S., Patella, S., Ostapowicz, G., Desmond, P. and Sievert, W. (2001) Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection. J. Viral Hepatitis 8, 406-413
206. Iio, S., Hayashi, N., Mita, E. et al. (1998) Serum levels of soluble Fas antigen in chronic hepatitis C patients. J. Hepatol. 29, 517-523
207. Calabrese, F., Pontisso, P., Pettenazzo, E. et al. (2000) Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 31, 1153-1159
208. Bantel, H., Lugering, A., Heidemann, J. et al. (2004) Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 40, 1078-1087
209. Bantel, H., Lugering, A., Poremba, C. et al. (2001) Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 34, 758-767
210. Hiramatsu, N., Hayashi, N., Haruna, Y. et al. (1992) Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology 16, 306-311
211. Linton, S. D., Aja, T., Armstrong, R. A. et al. (2005) First-in-class pan caspase inhibitor developed for the treatment of liver disease. J. Med. Chem. 48, 6779-6782
212. Sedger, L. M., Shows, D. M., Blanton, R. A. et al. (1999) IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol. 163, 920-926
213. Strater, J., Walczak, H., Pukrop, T. et al. (2002) TRAIL and its receptors in the colonie epithelium: a putative role in the defense of viral infections. Gastroenterology 122, 659-666
214. Sato, K., Hida, S., Takayanagi, H. et al. (2001) Antiviral response by natural killer cells through TRAIL gene induction by IFN-α/β. Eur. J. Immunol. 31, 3138-3146
215. Mundt, B., Wirth, T., Zender, L. et al. (2005) Tumor cecrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut 54, 1550-1556
216. Chou, A. H., Tsai, H. F., Wu, Y. Y. et al. (2005) Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J. Immunol. 174, 2160-2166
217. Lee, S. H., Kim, Y. K., Kim, C. S. et al. (2005) E2 of hepatitis C virus inhibits apoptosis. J. Immunol. 175, 8226-8235